Grufity logoGrufity logo

Metlife Inc Stock Research

MET

55.85USD+1.50(+2.76%)Delayed

Market Summary

USD55.85+1.50
Delayed
2.76%

MET Alerts

MET Stock Price

MET RSI Chart

MET Valuation

Market Cap

43.5B

Price/Earnings (Trailing)

17.14

Price/Sales (Trailing)

0.62

EV/EBITDA

6.19

Price/Free Cashflow

3.3

MET Price/Sales (Trailing)

MET Profitability

EBT Margin

4.09%

Return on Equity

9.39%

Return on Assets

0.38%

Free Cashflow Yield

30.35%

MET Fundamentals

MET Revenue

Revenue (TTM)

69.9B

Revenue Y/Y

-18.78%

Revenue Q/Q

-26.74%

MET Earnings

Earnings (TTM)

2.5B

Earnings Y/Y

11.45%

Earnings Q/Q

240%

Price Action

52 Week Range

54.5277.36
(Low)(High)

Last 7 days

-2.0%

Last 30 days

-22.3%

Last 90 days

-22.8%

Trailing 12 Months

-19.9%

MET Financial Health

MET Investor Care

Dividend Yield

3.55%

Dividend/Share (TTM)

1.98

Buy Backs (1Y)

5.63%

Diluted EPS (TTM)

2.91

Peers (Alternatives to Metlife)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
43.5B
69.9B
-22.26% -19.90%
17.14
0.62
-1.66% -61.26%
38.7B
60.0B
-19.83% -31.95%
125.56
0.61
-15.34% -118.62%
38.6B
36.9B
-9.77% -9.50%
13.59
1.05
5.94% -22.39%
24.4B
12.1B
-9.44% 18.99%
40.95
2.03
1.63% -56.71%
17.0B
7.6B
- -
-9.57
0.74
-71.04% -207.85%
11.4B
5.2B
-11.08% 6.55%
15.43
2.19
2.00% -0.71%
MID-CAP
6.0B
2.7B
-9.25% 22.62%
15.97
2.19
0.38% -0.09%
3.6B
18.8B
-34.02% -68.17%
-1.6
0.19
-2.32% -258.51%
3.0B
1.4B
-11.34% -8.75%
2.46
2.12
-61.63% 157.59%
2.9B
8.5B
-25.52% -20.81%
574.08
0.34
18.64% 104.63%
2.4B
7.5B
-20.61% 30.10%
4.02
0.33
-4.15% -32.63%
SMALL-CAP
119.9M
101.8M
15.75% 57.38%
-7.08
1.18
-19.68% 11.97%
49.1M
192.4M
3.33% -12.98%
15.61
0.26
-8.30% -76.65%
41.4M
-
0.80% 56.55%
-121.51
0.63
- -

Financials for Metlife

Income Statement (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Revenue-5.1%69,89873,67168,30671,27471,080
Operating Expenses-0.5%12,03412,09712,65812,45612,586
  S&GA Expenses0.1%5,2705,2645,463--
EBITDA12.8%3,7643,3374,9709,461-
EBITDA Margin18.9%0.05*0.05*0.07*0.13*-
Earnings Before Taxes17.3%2,8592,4384,0618,5508,126
EBT Margin23.6%0.04*0.03*0.06*0.12*-
Interest Expenses0.7%905899909911914
Net Income5.5%2,5392,4063,5956,8706,554
Net Income Margin11.2%0.04*0.03*0.05*0.10*-
Free Cahsflow-17.5%13,20416,01015,23813,054-
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Assets2.5%666,611650,104662,893724,284759,708
    Cash Equivalents-9.0%20,19522,20020,54823,48820,047
  Goodwill3.2%9,2979,0059,1519,5109,535
Liabilities2.3%639,324624,774625,526670,047691,959
.    Short Term Borrowings-4.4%175183196323341
Shareholder's Equity7.8%27,04025,07637,36754,23767,482
  Retained Earnings2.2%41,95341,03241,10141,40641,197
  Additional Paid-In Capital0.1%33,61633,58933,54833,53133,511
Shares Outstanding-1.0%779787798815826
Minority Interest-2.8%247254266272267
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Cashflow From Operations-17.5%13,20416,01015,23813,05412,596
Cashflow From Investing50.4%-2,620-5,285-9,453-10,559-11,187
Cashflow From Financing-49.9%-10,108-6,742-9,6251,140-1,375
  Dividend Payments-0.7%1,5981,6101,6231,6361,647
  Buy Backs-14.8%3,3263,9064,2474,2444,303

Risks for MET

What is the probability of a big loss on MET?

39.6%


Probability that Metlife stock will be more than 20% underwater in next one year

19.6%


Probability that Metlife stock will be more than 30% underwater in next one year.

18.9%


Probability that Metlife stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does MET drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Metlife was unfortunately bought at previous high price.

Drawdowns

Returns for MET

Cumulative Returns on MET

8.5%


10-Year Cumulative Returns

9.1%


7-Year Cumulative Returns

7.7%


5-Year Cumulative Returns

26.0%


3-Year Cumulative Returns

What are the long-term rolling returns for MET?

FIve years rolling returns for Metlife.

Annualized Returns

Which funds bought or sold MET recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-03-23
MetLife Investment Management, LLC
reduced
-3.22
1,647,700
12,459,000
0.10%
2023-03-23
ETF MANAGERS GROUP, LLC
added
4.27
144,602
743,602
0.04%
2023-03-17
American Portfolios Advisors
reduced
-3.31
-22,261
325,267
0.01%
2023-03-15
B. Riley Wealth Advisors, Inc.
reduced
-2.58
116,220
924,220
0.03%
2023-03-10
VICTORY CAPITAL MANAGEMENT INC
reduced
-6.57
8,485,010
83,929,000
0.09%
2023-03-10
MATHER GROUP, LLC.
reduced
-1.71
50,060
345,060
0.01%
2023-03-08
Capital Asset Advisory Services LLC
reduced
-18.16
13,413
1,179,410
0.09%
2023-03-07
Great Lakes Retirement, Inc.
new
-
6,172,190
6,172,190
1.58%
2023-03-07
Nordwand Advisors, LLC
new
-
7,708,490
7,708,490
0.96%
2023-03-06
BIRMINGHAM CAPITAL MANAGEMENT CO INC/AL
reduced
-1.08
424,706
2,810,710
1.07%

1–10 of 47

Latest Funds Activity

Are funds buying MET calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own MET
No. of Funds

Metlife News

MarketBeat

Bank of Montreal Can Has $118.34 Million Stock Position in MetLife ....

MarketBeat,
18 minutes ago

MarketWatch

InvestorsObserver

RealMoney

Marketscreener.com

METLIFE - CAN EMPLOYERS AFFORD NOT TO CARE.

Marketscreener.com,
7 days ago

InvestorsObserver

Schedule 13G FIlings of Metlife

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 23, 2023
board of directors of metlife inc
15.9%
122,923,807
SC 13D/A
Feb 14, 2023
dodge & cox
6.8%
53,583,210
SC 13G/A
Feb 09, 2023
vanguard group inc
7.08%
55,519,588
SC 13G/A
Jan 31, 2023
blackrock inc.
7.1%
55,514,415
SC 13G/A
May 05, 2022
board of directors of metlife inc
15.6%
127,128,424
SC 13D/A
Feb 14, 2022
dodge & cox
7.0%
58,725,183
SC 13G/A
Feb 09, 2022
vanguard group inc
6.77%
56,951,725
SC 13G/A
Feb 03, 2022
blackrock inc.
8.5%
71,686,373
SC 13G/A
Nov 09, 2021
board of directors of metlife inc
15.5%
130,169,694
SC 13D/A
Aug 06, 2021
board of directors of metlife inc
15.4%
131,995,674
SC 13D/A

MET Fair Value

Metlife fair value in different scenarios

The table shows the Fair Value estimates for Metlife for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
Fair ValueVery PessimisticPessimisticBase CaseOptimisticVery Optimistic
Very Low Inflation

-

-

6.33

-88.67%

22.20

-60.25%

60.97

9.17%

81.34

45.64%
Current Inflation

9.70

-82.63%

1.72

-96.92%

15.19

-72.80%

47.69

-14.61%

64.72

15.88%
Very High Inflation

-

-

-

-

6.75

-87.91%

32.20

-42.35%

45.51

-18.51%

Historical Metlife Fair Value Estimates


Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price

Recent SEC filings of Metlife

View All Filings
Date Filed Form Type Document
Mar 23, 2023
13F-HR
Fund Holdings Report
Mar 23, 2023
13F-HR/A
Fund Holdings Report
Mar 23, 2023
13F-HR/A
Fund Holdings Report
Mar 23, 2023
13F-HR/A
Fund Holdings Report
Mar 23, 2023
13F-HR/A
Fund Holdings Report
Mar 23, 2023
13F-HR/A
Fund Holdings Report
Mar 23, 2023
13F-HR
Fund Holdings Report
Mar 23, 2023
13F-HR
Fund Holdings Report
Mar 23, 2023
13F-HR
Fund Holdings Report
Mar 23, 2023
13F-HR
Fund Holdings Report

Latest Insider Trading transactions for MET

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-03-14
HUBBARD ROBERT GLENN
acquired
37,686
59.07
638
-
2023-03-14
Kennard William E
acquired
17,130
59.07
290
-
2023-03-14
KELLY EDWARD J III
acquired
14,413
59.07
244
-
2023-03-14
GRISE CHERYL W
acquired
36,150
59.07
612
-
2023-03-14
MCKENZIE DIANA
acquired
7,147
59.07
121
-
2023-03-14
Kinney Catherine R
acquired
17,602
59.07
298
-
2023-03-14
Herzog David L
acquired
2,835
59.07
48.00
-
2023-03-14
HASSELL GERALD L
acquired
8,447
59.07
143
-
2023-03-02
PAPPAS BILL
sold
-202,733
70.96
-2,857
evp, global tech. & ops.
2023-03-01
GAUSTER STEPHEN W
sold (taxes)
-155,084
71.27
-2,176
evp & general counsel

1–10 of 50

About Metlife

MET Income Statement

2022-12-31
Consolidated Statements of Operations - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Revenues   
Premiums$ 49,397$ 42,009$ 42,034
Universal life and investment-type product policy fees5,5855,7565,603
Net investment income15,91621,39517,117
Other revenues2,6342,6191,849
Net investment gains (losses)(1,262)1,529(110)
Net derivative gains (losses)(2,372)(2,228)1,349
Total revenues69,89871,08067,842
Expenses   
Policyholder benefits and claims50,61243,95441,461
Interest credited to policyholder account balances3,6925,5385,214
Policyholder dividends7018761,090
Other expenses12,03412,58613,150
Total expenses67,03962,95460,915
Income (loss) before provision for income tax2,8598,1266,927
Provision for income tax expense (benefit)3011,5511,509
Net income (loss)2,5586,5755,418
Less: Net income (loss) attributable to noncontrolling interests192111
Net income (loss) attributable to MetLife, Inc.2,5396,5545,407
Less: Preferred stock dividends185195202
Preferred stock redemption premium0614
Net income (loss) available to MetLife, Inc.’s common shareholders$ 2,354$ 6,353$ 5,191
Net income (loss) available to MetLife, Inc.’s common shareholders per common share:   
Basic$ 2.93$ 7.36$ 5.72
Diluted$ 2.91$ 7.31$ 5.68

MET Balance Sheet

2022-12-31
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Investments:  
Fixed maturity securities available-for-sale, at estimated fair value (net of allowance for credit loss of $183 and $91, respectively); and amortized cost: $306,025 and $310,884, respectively$ 276,780$ 340,274
Equity securities, at estimated fair value1,6841,269
Contractholder-directed equity securities and fair value option securities, at estimated fair value9,66812,142
Mortgage loans (net of allowance for credit loss of $527 and $634, respectively; includes $0 and $127, respectively, under the fair value option)83,76379,353
Policy loans8,8749,111
Real estate and real estate joint ventures (includes $299 and $240, respectively, under the fair value option and $0 and $175, respectively, of real estate held-for-sale)13,13712,216
Other limited partnership interests14,41414,625
Short-term investments, principally at estimated fair value4,9357,176
Other invested assets (net of allowance for credit loss of $26 and $40, respectively; includes $1,926 and $1,930, respectively, of leveraged and direct financing leases; and $326 and $351, respectively, relating to variable interest entities)20,03818,655
Total investments433,293494,821
Cash and cash equivalents, principally at estimated fair value20,19520,047
Accrued investment income3,4463,185
Premiums, reinsurance and other receivables17,46117,149
Deferred policy acquisition costs and value of business acquired22,98316,061
Current income tax recoverable42184
Deferred income tax assets2,830189
Goodwill9,2979,535
Assets held-for-sale07,238
Other assets11,02611,426
Separate account assets146,038179,873
Total assets666,611759,708
Liabilities  
Future policy benefits204,228199,721
Policyholder account balances203,082203,473
Other policy-related balances19,65117,751
Policyholder dividends payable387478
Policyholder dividend obligation01,682
Payables for collateral under securities loaned and other transactions20,93731,920
Short-term debt175341
Long-term debt14,64713,933
Collateral financing arrangement716766
Junior subordinated debt securities3,1583,156
Deferred income tax liability3259,693
Liabilities held-for-sale06,634
Other liabilities25,98022,538
Separate account liabilities146,038179,873
Total liabilities639,324691,959
Contingencies, Commitments and Guarantees (Note 21)
MetLife, Inc.’s stockholders’ equity:  
Preferred stock, par value $0.01 per share; $3,905 aggregate liquidation preference00
Common stock, par value $0.01 per share; 3,000,000,000 shares authorized; 1,189,831,471 and 1,186,540,473 shares issued, respectively; 779,098,414 and 825,540,267 shares outstanding, respectively1212
Additional paid-in capital33,61633,511
Retained earnings41,95341,197
Treasury stock, at cost; 410,733,057 and 361,000,206 shares, respectively(21,458)(18,157)
Accumulated other comprehensive income (loss)(27,083)10,919
Total MetLife, Inc.’s stockholders’ equity27,04067,482
Noncontrolling interests247267
Total equity27,28767,749
Total liabilities and equity$ 666,611$ 759,708